Behavioral Health Technician Delivered Written Exposure Therapy
NCT ID: NCT06789887
Last Updated: 2025-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
150 participants
INTERVENTIONAL
2025-02-01
2028-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. How well does written exposure therapy help to reduce symptoms of posttraumatic stress for service members with PTSD?
2. Is sharing the therapy tasks with behavioral health technicians is a helpful approach for managing behavioral health clinic patient volume and improving patient outcomes?
We plan to recruit a total of 40-59 staff participants, as well as 150 active-duty patient participants with PTSD. We will randomize patient participants to one of two treatment conditions: 1) treatment-as-usual (TAU) or 2) TAU and 5 sessions of WET. Staff and participants will be recruited from two military treatment facilities: 1) Fort Sam Houston in San Antonio (Brooke Army Medical Center) and 2) Camp Pendleton (Naval Hospital at Camp Pendleton).
Consented patient participants will:
* Complete a PTSD interview via telehealth with a study team member to determine if you are eligible for the study
* Be randomly assigned to one of the following conditions: 1) TAU + WET or 2) TAU
* Complete up to 8 weeks of behavioral health treatment (either TAU + WET or TAU)
* Complete self-report measures before, during, and after treatment, and at a 3- and 6-month follow up assessment after the treatment period
* Complete a posttreatment PTSD interview via telehealth with a study team member
* A subset of participants will be asked to complete a brief treatment experience interview posttreatment
Consented staff participants will:
* Participate in an interview about your perceptions of and experiences supporting BHT-delivered WET with a study team member at the VAPAHCS
* A subset of participants will also be asked to participate in a brief staff feedback interview approximately 6 months after their first interview
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brief Cognitive Behavioral Treatment of Deployment-Related PTSD Symptoms in Primary Care Settings
NCT02290639
Psychotherapy Treatment of Deployment-Related PTSD in Primary Care Settings
NCT00974402
Brief Treatment for Posttraumatic Stress Disorder
NCT03033602
Written Exposure Therapy for Posttraumatic Stress Disorder
NCT01800773
Implementation of Prolonged Exposure in the Military
NCT02982538
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment As Usual (TAU)
Participants in this arm will receive usually prescribed behavioral health treatment.
Treatment as Usual (TAU)
Treatment as usual (TAU) will be available to all patient participants. Treatment as usual may include various forms of psychotherapy and or medication management.
Treatment As Usual (TAU) and Written Exposure Therapy (WET)
Participants in this arm will receive the usually prescribed behavioral health treatment as well as 5 total sessions of Written Exposure Therapy with a Behavioral Health Technician.
Written Exposure Therapy
Written Exposure Therapy (WET) is a 5-session, trauma-focused intervention in which individuals write about their traumatic experience following scripted instructions.
Treatment as Usual (TAU)
Treatment as usual (TAU) will be available to all patient participants. Treatment as usual may include various forms of psychotherapy and or medication management.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Written Exposure Therapy
Written Exposure Therapy (WET) is a 5-session, trauma-focused intervention in which individuals write about their traumatic experience following scripted instructions.
Treatment as Usual (TAU)
Treatment as usual (TAU) will be available to all patient participants. Treatment as usual may include various forms of psychotherapy and or medication management.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Adult active duty personnel ages ≥18
2. Clinically significant PTSD symptoms (CAPS-5 ≥ 25).
Clinic staff participants: Individuals working as BHTs, clinic providers, and clinic leaders working at the behavioral health clinics participating in the study
Exclusion Criteria
1. Current suicide or homicide risk meriting crisis intervention
2. Serious mental health symptoms, such as mania, psychosis, alcohol or substance use disorders warranting immediate attention
3. Inability to comprehend the baseline screening questionnaires
4. Definite plans to leave the military within 10 weeks
Clinic staff participants:
None
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uniformed Services University of the Health Sciences
FED
The University of Texas Health Science Center at San Antonio
OTHER
Brooke Army Medical Center
FED
Naval Hospital Camp Pendleton
FED
NDRI-USA, Inc.
OTHER
Palo Alto Veterans Institute for Research
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCA0011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.